Blood type as a risk factor for pancreatic ductal adenocarcinoma

被引：0
|
作者：
Larki, Navid Rahimi
Skanderson, Melissa
Tate, Janet
Levinson, Rachel
Hauser, Ronald G.
Brandt, Cynthia
Yang, Yu-Xiao
Justice, Amy C.
Wang, Louise
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] VA Connecticut Healthcare Syst, West Haven, CT USA
[3] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10559
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis
    Takahashi, Hideo
    Katsuta, Eriko
    Yan, Li
    Tokumaru, Yoshihisa
    Katz, Matthew H. G.
    Takabe, Kazuaki
    CANCERS, 2020, 12 (08) : 1 - 12
  • [12] Peripheral blood immune phenotypes in pancreatic ductal adenocarcinoma
    Pavelko, Kevin D.
    Villasboas, Jose C.
    Taylor, William R.
    Doering, Karen A.
    Kisiel, John B.
    Majumder, Shounak
    CANCER RESEARCH, 2024, 84 (06)
  • [13] Associations between genetically predicted blood protein biomarkers and pancreatic ductal adenocarcinoma risk
    Zhu, Jingjing
    Shu, Xiang
    Guo, Xingyi
    Liu, Duo
    Bao, Jiandong
    Milne, Roger
    Giles, Graham G.
    Wu, Chong
    Du, Mengmeng
    White, Emily
    Risch, Harvey A.
    Malats, Nuria
    Duell, Eric J.
    Goodman, Phyllis J.
    Li, Donghui
    Bracci, Paige
    Katzke, Verena
    Neale, Rachel E.
    Gallinger, Steven
    Van den Eeden, Stephen
    Arslan, Alan
    Canzian, Federico
    Kooperberg, Charles
    Wolpin, Brian
    Beane-Freeman, Laura
    Scelo, Ghislaine
    Visvanatha, Kala
    Haiman, Christopher A.
    Le Marchand, Loic
    Yu, Herbert
    Petersen, Gloria M.
    Stolzenberg-Solomon, Rachael
    Klein, Alison P.
    Amundadottir, Laufey T.
    Cai, Qiuyin
    Long, Jirong
    Shu, Xiao-Ou
    Zheng, Wei
    Wu, Lang
    CANCER RESEARCH, 2020, 80 (16)
  • [14] Medicaid or Uninsured Status is an Independent Risk Factor for Mortality in Patients With Pancreatic Ductal Adenocarcinoma
    Mukhija, D.
    Sohal, D. P. S.
    PANCREAS, 2018, 47 (10) : 1411 - 1411
  • [15] The State of the Art on Blood MicroRNAs in Pancreatic Ductal Adenocarcinoma
    Gao, Zhuqing
    Jiang, Wei
    Zhang, Shutian
    Li, Peng
    ANALYTICAL CELLULAR PATHOLOGY, 2019, 2019
  • [16] An Overview of Genetic Changes and Risk of Pancreatic Ductal Adenocarcinoma
    Sarnecka, Agnieszka K.
    Zagozda, Malgorzata
    Durlik, Marek
    JOURNAL OF CANCER, 2016, 7 (14): : 2045 - 2051
  • [17] Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
    Michalak, Natalia
    Malecka-Wojciesko, Ewa
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [18] Pancreatic Ductal Adenocarcinoma: Time Course of Risk Factors
    Simon, Annika
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (08): : 971 - +
  • [19] Pancreatic ductal adenocarcinoma
    Gallmeier, E.
    Gress, T. M.
    INTERNIST, 2018, 59 (08): : 805 - 822
  • [20] Pancreatic Ductal Adenocarcinoma
    Heinemann, V.
    Schmidberger, H.
    ONKOLOGE, 2019, 25 (08): : 642 - 644
12345